| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9808ce62b75113e904f80f43e54cd29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_355252650b8ea60ddbab74d5b4afd0f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dac4f0cf6a52dbbaf963c6308da29993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae658dfcd5130f0a62f9f4e0f047bac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6e680eb91b7347e177c54a6e2ff62be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76c0431c72d9e1a7ce07bd3a80b6661c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f39048e686609630aa74e1ec9f9f3165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6073e71a8b7f800d414a06bff04a49c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
1996-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3cc097235804a1bac084ba9fa8dc612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af16eb793c955766ed7251dd69b5472c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ecc072c86747bc112b6faf12499958e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8486b16c27f46aa8c6d121ada6e43637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff58303e18db70a3527ef4c1cb8da5aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ddac91d67802e1521ce36d3c2e7a463 |
| publicationDate |
1998-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9829139-A1 |
| titleOfInvention |
PREPARATION CONTAINING AN ORGANIC COMPOUND LABELLED WITH A β RADIONUCLIDE |
| abstract |
The present invention relates to the production of preparations containing biologically active compounds that have been labelled using a β radionuclide such as phosphorus 32, phosphorus 33 or sulphur 35. These preparations may be used in biological research as well as for medical purposes. This invention essentially relates to a preparation containing a water-soluble organic compound which has been labelled using a β radionuclide. The preparation also includes a radio-protector which may consist in a substance from the porphyrin class or a polymeric form thereof, wherein said substance may for example be a cyancobalamine and has an optimal concentration in the preparation ranging from 0.1 to 4.0 mg/ml. The addition to this preparation of trioxymethylaminomethane in an amount of between 40 and 60 m.moles/l. improves the labelled compound stability and increases the shelf life of said preparation as well as its storage and transportation temperature up to a 0 to 25 °C range. This invention also facilitates visual monitoring when working with micro-quantities of radioactive preparation without the need for any additional coloration system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007011021-A1 |
| priorityDate |
1996-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |